 Cases and controls for this study will be recruited from among the acute lymphocytic leukemia ALL survivor members of the St. Jude Lifetime Cohort study SJLIFE. Cases will be matched for gender, tumor type, estimated cumulative vincristine dose at which toxicity occurred, intended vincristine chemotherapy regimen, age within 5 years and race with existing controls. 